Literature DB >> 20007286

Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

Cintia S De Paiva1, Cindy S Hwang, John D Pitcher, Solherny B Pangelinan, Ehsan Rahimy, Wei Chen, Kyung-Chul Yoon, William J Farley, Jerry Y Niederkorn, Michael E Stern, De-Quan Li, Stephen C Pflugfelder.   

Abstract

OBJECTIVES: IL-2ralpha (CD25)(-/-) mice develop autoimmunity and lymphoproliferative disorders, including SS-like disease. The objective of this study was to evaluate the severity of corneal epithelial disease and T-cell cytokine profile in the ocular surface tissues of CD25KO mice.
METHODS: CD25KO mice were evaluated at 8, 12 and 16 weeks of age. Corneal epithelial smoothness and corneal permeability were measured. Phenotype of infiltrating lymphocytes was evaluated by immunohistochemistry. Th-1, -2 and -17 associated factors were measured by real-time PCR in cornea and conjunctiva and by Luminex immunobead assay in tears.
RESULTS: Compared with 8-week-old wild-type (WT) mice, CD25KO mice of the same age had significantly greater corneal irregularity and a significant increase in the number of CD4(+) and CD8(+) T cells infiltrating the conjunctiva. CD25KO mice had significantly higher levels of IL-6, TGF-beta1, IL-23R, IL-17A, IL-17F, IL-21, CCL20, IL-10, GATA-3 and IFN-gamma mRNA transcripts in their cornea and conjunctiva than WT mice at 8 weeks. IL-17A and IL-17F mRNA transcripts peaked at 12 weeks, whereas IFN-gamma spiked at 16 weeks in CD25KO mice. Increased expression of IL-17A and IL-17F at 12 weeks in CD25KO mice was accompanied by a worsening of corneal surface parameters and an increase of CD4(+) T cell infiltrating the cornea.
CONCLUSIONS: Disruption of IL-2 signalling in CD25KO mice results in age-dependent SS-like autoimmune lacrimal-keratoconjunctivitis. A mix of Th-1 and Th-17 cytokines was detected. The peak severity of corneal epithelial disease corresponded to the peak of IL-17 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007286      PMCID: PMC2909796          DOI: 10.1093/rheumatology/kep357

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  55 in total

Review 1.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.

Authors:  T A Waldmann; S Dubois; Y Tagaya
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

Review 2.  A review and update of Sjögren's syndrome: manifestations, diagnosis, and treatment.

Authors:  S Carsons
Journal:  Am J Manag Care       Date:  2001-09       Impact factor: 2.229

3.  Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IqI/Jic mouse model of primary Sjörgren's syndrome.

Authors:  Akihiro Konno; Kensuke Takada; Junzo Saegusa; Mitsuyoshi Takiguchi
Journal:  Autoimmunity       Date:  2003-06       Impact factor: 2.815

4.  Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome.

Authors:  Shizuka Tsunawaki; Seiji Nakamura; Yukiko Ohyama; Masanori Sasaki; Akiko Ikebe-Hiroki; Akimitsu Hiraki; Tsutomu Kadena; Eui Kawamura; Wataru Kumamaru; Masanori Shinohara; Kanemitsu Shirasuna
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

5.  Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study.

Authors:  Alexandros Andrianakos; Panagiotis Trontzas; Fotis Christoyannis; Petros Dantis; Costas Voudouris; Athanasios Georgountzos; George Kaziolas; Elizabeth Vafiadou; Kyriaki Pantelidou; Dimitrios Karamitsos; Leonidas Kontelis; Petros Krachtis; Zouboulio Nikolia; Evaggelia Kaskani; Elpiniki Tavaniotou; Christos Antoniades; George Karanikolas; Anastasia Kontoyanni
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

6.  Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.

Authors:  Susumu Nakae; Aya Nambu; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

7.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.

Authors:  Susumu Nakae; Yutaka Komiyama; Aya Nambu; Katsuko Sudo; Michiko Iwase; Ikuo Homma; Kenji Sekikawa; Masahide Asano; Yoichiro Iwakura
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

8.  Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

Authors:  Cuong Q Nguyen; Min H Hu; Yi Li; Carol Stewart; Ammon B Peck
Journal:  Arthritis Rheum       Date:  2008-03

9.  Age- and gender-related differences in human lacrimal fluid peroxidase activity.

Authors:  Giordana Marcozzi; Veronica Liberati; Federica Madia; Marco Centofanti; Giuseppe de Feo
Journal:  Ophthalmologica       Date:  2003 Jul-Aug       Impact factor: 3.250

10.  Apoptosis of ocular surface cells in experimentally induced dry eye.

Authors:  Steven Yeh; Xiu Jun Song; William Farley; De-Quan Li; Michael E Stern; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

View more
  56 in total

1.  sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

Authors:  Yi Wei; Seth P Epstein; Shima Fukuoka; Neil P Birmingham; Xiu-Min Li; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

2.  Spontaneous autoimmune dacryoadenitis in aged CD25KO mice.

Authors:  Ehsan Rahimy; John D Pitcher; Solherny B Pangelinan; Wei Chen; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder; Cintia S De Paiva
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

3.  The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.

Authors:  Thomas H Dohlman; Sunil K Chauhan; Shilpa Kodati; Jing Hua; Yihe Chen; Masahiro Omoto; Zahra Sadrai; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

Review 4.  T helper cytokines in dry eye disease.

Authors:  Stephen C Pflugfelder; Rosa M Corrales; Cintia S de Paiva
Journal:  Exp Eye Res       Date:  2013-09-04       Impact factor: 3.467

5.  Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.

Authors:  Yi Wei; Neha Gadaria-Rathod; Seth Epstein; Penny Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-23       Impact factor: 4.799

6.  Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.

Authors:  Rodrigo Guimaraes de Souza; Zhiyuan Yu; Michael E Stern; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  J Ocul Pharmacol Ther       Date:  2018-06-29       Impact factor: 2.671

Review 7.  The core mechanism of dry eye disease is inflammation.

Authors:  Yi Wei; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2014-07       Impact factor: 2.018

Review 8.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

9.  A pathogenetic role for IL-21 in primary Sjögren syndrome.

Authors:  Seung-Ki Kwok; Jennifer Lee; Di Yu; Kwi Young Kang; Mi-La Cho; Hae-Rim Kim; Ji Hyeon Ju; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Nat Rev Rheumatol       Date:  2015-01-13       Impact factor: 20.543

10.  STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren's syndrome.

Authors:  Kwong Tai Cheng; Ilias Alevizos; Xibao Liu; Wiliam D Swaim; Hongen Yin; Stefan Feske; Masatsugu Oh-hora; Indu S Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.